Colgate Palmolive CO CL
We take great care to ensure that the data presented and summarized in this overview for COLGATE PALMOLIVE CO is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CL
View all-
Vanguard Group Inc Valley Forge, PA79.6MShares$7.64 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY59.5MShares$5.71 Billion0.13% of portfolio
-
State Street Corp Boston, MA46.1MShares$4.43 Billion0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD41.1MShares$3.94 Billion0.45% of portfolio
-
Wellington Management Group LLP Boston, MA27.8MShares$2.67 Billion0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA19.1MShares$1.83 Billion0.16% of portfolio
-
Morgan Stanley New York, NY18.3MShares$1.76 Billion0.13% of portfolio
-
Amundi Paris, I013.8MShares$1.32 Billion0.52% of portfolio
-
First Eagle Investment Management, LLC10.6MShares$1.01 Billion2.18% of portfolio
-
Northern Trust Corp Chicago, IL8.78MShares$843 Million0.14% of portfolio
Latest Institutional Activity in CL
Top Purchases
Top Sells
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Insider Transactions at CL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2024
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
22,250
-27.15%
|
$2,091,500
$94.15 P/Share
|
May 14
2024
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
22,250
+21.35%
|
$1,602,000
$72.29 P/Share
|
May 13
2024
|
Martina Hundmejean Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+15.33%
|
-
|
May 13
2024
|
John T Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+6.62%
|
-
|
May 13
2024
|
Kimberly A Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+20.9%
|
-
|
May 13
2024
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+8.24%
|
-
|
May 13
2024
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+12.11%
|
-
|
May 13
2024
|
Steven A Cahillane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+28.76%
|
-
|
May 13
2024
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+5.27%
|
-
|
May 13
2024
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+5.59%
|
-
|
May 13
2024
|
Brian Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,587
+46.75%
|
-
|
May 09
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Open market or private sale
|
Direct |
12,000
-70.1%
|
$1,128,000
$94.15 P/Share
|
May 09
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+41.21%
|
$864,000
$72.29 P/Share
|
May 09
2024
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,226
-46.75%
|
$1,149,244
$94.06 P/Share
|
May 09
2024
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,226
+31.86%
|
$880,272
$72.29 P/Share
|
May 07
2024
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
3,497
-52.37%
|
$325,221
$93.47 P/Share
|
May 01
2024
|
John P Bilbrey Director |
SELL
Open market or private sale
|
Direct |
6,329
-17.31%
|
$575,939
$91.59 P/Share
|
May 01
2024
|
John P Bilbrey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,329
+14.76%
|
$392,398
$62.04 P/Share
|
May 01
2024
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,115
-30.52%
|
$556,465
$91.92 P/Share
|
May 01
2024
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,115
+23.38%
|
$440,280
$72.29 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 192K shares |
---|---|
Exercise of conversion of derivative security | 486K shares |
Open market or private sale | 544K shares |
---|---|
Payment of exercise price or tax liability | 34.2K shares |
Discretionary transaction | 836 shares |